Incorporation of GluR1-containing AMPA receptors into synapses is essential to several forms of neural plasticity, including long-term potentiation (LTP). Numerous signaling pathways that trigger this process have been identified, but the direct modifications of GluR1 that control its incorporation into synapses are unclear. Here, we show that phosphorylation of GluR1 by PKC at a highly conserved serine 818 residue is increased during LTP and critical for LTP expression. GluR1 is phosphorylated by PKC at this site in vitro and in vivo. In addition, acute phosphorylation at GluR1 S818 by PKC, as well as a phosphomimetic mutation, promotes GluR1 synaptic incorporation. Conversely, preventing GluR1 S818 phosphorylation reduces LTP and blocks PKC-driven synaptic incorporation of GluR1. We conclude that the phosphorylation of GluR1 S818 by PKC is a critical event in the plasticity-driven synaptic incorporation of AMPA receptors.
Introduction
Stable incorporation of AMPA-type glutamate receptors (AMPA-Rs) into synapses underlies several forms of synaptic plasticity (reviewed in Maren [2005] ). Given the importance of neural plasticity to adaptive behavior, the signaling events controlling AMPA receptor trafficking are likely to be multifaceted and complex. This view has been borne out by studies that have implicated several signaling pathways in the generation of LTP (Sheng and Kim, 2002) , a widely studied model of synaptic plasticity that requires synaptic incorporation of AMPA-Rs (Barry and Ziff, 2002; Bredt and Nicoll, 2003; Collingridge and Singer, 1990; Malinow and Malenka, 2002; Scannevin and Huganir, 2000) .
AMPA receptors are tetramers composed of variable combinations of the receptor subunits, GluR1, GluR2, GluR3, and GluR4, which assemble into a pore-forming and transmitter-sensitive complex (Hollmann and Heinemann, 1994; Wisden and Seeburg, 1993) . In adult hippocampus, AMPA receptor complexes contain GluR1 and GluR2 or GluR3 and GluR2 (Wenthold et al., 1996) . These subunits can also bind to cytoplasmic and transmembrane proteins that control their subcellular distribution (Barry and Ziff, 2002; Bredt and Nicoll, 2003; Collingridge and Singer, 1990; Malinow and Malenka, 2002; Scannevin and Huganir, 2000) . Several lines of evidence point to a central role for the GluR1 subunit in hippocampal LTP. GluR1 2/2 mice are deficient in LTP (Zamanillo et al., 1999) , knockin mutations in the GluR1 CaM kinase II and PKA phosphorylation sites have partial deficits in LTP expression (Lee et al., 2003) , and GluR1-containing receptors are delivered into synapses during LTP .
Previous studies have shown that the cytoplasmic tail of each type of AMPA receptor subunit confers specific synaptic trafficking characteristics and signaling requirements (Passafaro et al., 2001; Shi et al., 2001) . For example, both GluR1 and GluR4 subunits require plasticity-inducing synaptic activity to drive them into synapses, but the signaling controlling their trafficking is different. Direct PKA phosphorylation of the cytoplasmic terminus during LTP-inducing stimuli is sufficient to drive GluR4-containing AMPA receptors into synapses (Esteban et al., 2003) . In contrast, direct phosphorylation of GluR1 by PKA is not sufficient for its synaptic incorporation, and additional signaling events are required (Esteban et al., 2003) . This molecular distinction parallels the change in pharmacological sensitivity of LTP during development: GluR4 is expressed early when LTP is PKA dependent, while GluR1 is expressed later when other kinases participate (Yasuda et al., 2003; Zhu et al., 2000) .
The additional molecular events that control GluR1 synaptic incorporation have been somewhat elusive. Several protein kinases, including the calcium/calmodulin-dependent protein kinase II (CaMKII) and PKC have been implicated in LTP (e.g., Ling et al., 2002; Lisman et al., 1997; Malenka et al., 1986; Malinow et al., 1989) . Serine 831 (S831) on GluR1 is a substrate for CaMKII and PKC and undergoes phosphorylation during LTP. Mutation of GluR1 S831 to alanine, however, does not prevent its incorporation into synapses . In addition, although mice containing knockin mutations in S831 and S845 have large deficiencies in LTD, they only have partial deficits in LTP (Lee et al., 2003) .
To further investigate the molecular determinants of GluR1 trafficking, we analyzed the differential structural requirements of GluR1 and GluR4 trafficking. Experiments using chimeric GluR1/GluR4 subunits identified a region of the cytoplasmic tail immediately after the last membrane-spanning region (membrane proximal region, MPR) as a critical determinant of subunit specific trafficking. Although the MPR is highly conserved (12 of 14 amino acids) among the four subunits, two serine residues (S816 and S818) in GluR1 are alanine residues in GluR4 ( Figure 1A ). Site-specific mutations of these residues indicate that they determine the differential trafficking of these subunits. We noted that S818 in GluR1 is conserved among humans, rodents, fowl, fish, and snail ( Figure 1B ). Interestingly, we show that GluR1 S818 is a PKC phosphorylation site in vivo and in vitro, and moreover, phosphorylation of this site is increased during LTP. Acute PKC phosphorylation of this site or introduction of a phosphomimetic mutation, contribute to synaptic incorporation of GluR1. Lastly, dominant-negative constructs based on this residue block LTP. We conclude that direct phosphorylation of GluR1 S818 by PKC is a key step for synaptic GluR1 incorporation during LTP.
Results
The MPR Plays a Crucial Role in Glutamate-Receptor Trafficking To examine synaptic incorporation of recombinant receptors, we employed electrophysiological tagging . Organotypic hippocampal slices were infected with a Sindbis virus that drives expression of recombinant receptor subunits in pyramidal neurons. Such infection leads to formation of homomeric, inward rectifying AMPA receptors containing only the recombinant subunit. Two days after infection, evoked synaptic transmission onto infected neurons was monitored with whole-cell patch-clamp recordings. The magnitude of inward rectification displayed by synaptic transmission indicates the level of synaptic incorporation of recombinant receptors (see Experimental Procedures and Hayashi et al., 2000). As indicated in the Introduction, the expression profile of GluR4 and GluR1 changes dramatically between the first and second week in hippocampal development; GluR4 levels decrease while GluR1 increases. Therefore, organotypic slices prepared at P6 were maintained 2 days in vitro (DIV) for experiments examining GluR4 trafficking and maintained 10 DIV for experiments examining GluR1 trafficking.
Early during postnatal development, spontaneous activity in 2 DIV organotypic slices is sufficient to drive synaptic incorporation of recombinant GluR4, but not recombinant GluR1, in hippocampal pyramidal neurons Zhu et al., 2000; Figure 1C, top) . To examine domains that confer this different behavior, we generated chimeric proteins by swapping parts of GluR1 cytoplasmic terminus with corresponding regions of GluR4. Previous experiments successfully switched trafficking behavior of GuR1 and GluR2 by exchanging their cytoplasmic termini (Shi et al., 2001 ). We therefore expressed in 2 DIV slices a chimeric subunit composed of GluR1 with most of its cytoplasmic tail (from aa 823 to 882; see left diagrams, Figure 1C ) exchanged with that of GluR4. Slices were maintained in normal medium that permitted spontaneous neural activity. Surprisingly, this chimeric receptor failed to behave like GluR4; spontaneous activity was not sufficient to drive the chimeric receptor into synapses ( Figure 1C, middle) . However, incorporation of all of the cytoplasmic tail, (from aa 814 to 882; see left diagrams, Figure 1C ), which includes an additional 14 amino acids of GluR4, did confer GluR4-like trafficking properties to the chimeric protein ( Figure 1C , bottom) indicating that this MPR is critical for the differential trafficking. shows constitutive incorporation into the synapse (upper panel; control, 1.78 6 0.13; infected, 2.61 6 0.24; each, n = 12). Swapping the cytoplasmic terminus from GluR4 onto GluR1 without the MPR impairs the constitutive delivery of the chimeric receptor (middle; control, 1.81 6 0.10, n = 28; infected, 1.96 6 0.12, n = 29). In contrast, swapping the fulllength cytoplasmic terminus from GluR4 onto GluR1 leads to a GluR4-like trafficking of the chimeric receptor (bottom panel; control, 2.0 6 0.17, infected, 2.87 6 0.26; each, n = 12).
The sequences of the MPRs of GluR4 and GluR1 differ only in two residues, which must therefore underlie the differential trafficking. GluR1 has two serines at positions S816 and S818 that are alanines in GluR4 (see Figure 1A) . To examine the impact of these two residues on trafficking of GluR4 we mutated the sequence AlaGlu-Ala (''AEA'') to Ser-Glu-Ser (''SES''). Unlike wildtype GluR4, GluR4 with AEA changed to SES did not incorporate into synapses in 2 DIV slices with spontaneous neural activity (Figure 2A ), confirming that this site is critical for GluR4 synaptic incorporation. Interestingly, a similar modification (AEA to SES) in GluR2 did not change the trafficking behavior of GluR2 ( Figure 2B ), a subunit that is incorporated into synapses in the absence of plasticity-inducing stimuli, indicating that other regions of the carboxyl tail are critical for subunit specific regulation. Finally, mutating the GluR1 MPR to mimic that of GluR4 (SES to AEA) failed to incorporate GluR1 into the synapse in 10 DIV slices ( Figure 2C ). These results indicate that at the MPR the sequence AEA is required for GluR4 to traffic normally to synapses in 2 DIV slices; however, AEA is not sufficient to drive GluR1 into synapses of 10 DIV slices. This indicates that GluR1 has additional trafficking requirements.
These results indicating a critical importance of the MPR in GluR4 trafficking led us to investigate the role of this region in GluR1 trafficking. All subsequent organotypic slice experiments were conducted on 10 DIV organotypic slices. Since the serines in GluR1 MPR lie within consensus sequences for various protein kinases, we hypothesized that the additional signaling requirement conferred by the SES sequence in GluR1 is a phosphorylation event. To test this possibility, we examined whether these serine residues could be phosphorylated in vitro and in vivo.
In Vitro Phosphorylation of GluR1
To identify whether these serines were phosphorylation sites in the GluR1 carboxyl tail, we performed in vitro phosphorylation experiments using GST-fusion proteins of the GluR1 cytoplasmic domain (GST-GluR1C80) and brain lysates as a source of protein kinase activity. To selectively examine phosphorylation events in the MPR, we used a GST-GluR1C80 that contained serineto-alanine mutations (S/A) at the known CaMKII and PKA (S831 and S845) phosphorylation sites and at serine residues (S814, S816, and S818) within the MPR. Incubation of wild-type GST-GluR1C80 fusion protein with brain cell lysates and 32 P-ATP resulted in robust phosphorylation. Mutation of all five serines (S814, S816, S818, S831, and S845) eliminated this phosphorylation. Phosphorylation of the GST-GluR1C80 fusion protein was partially rescued by having a serine residue at S818 but not by restoring serine residues 814 or 816 (top of Figure 3A ). This result indicates that GluR1 S818 is a phosphorylation site for kinases in brain lysate. Although S814 and S816 were not phosphorylated, they are predicted to be potential casein kinase II sites following S818 phosphorylation (prediction by NetPhos; Blom et al., 1998) . We therefore generated a GST-GluR1C80 fusion protein carrying a serine-toaspartate mutation (S/D) at S818 to mimic phosphorylation at this site. However, S814 or S816 were still not phosphorylated under these conditions ( Figure 3A) . (B) The same mutation from AEA to SES in GluR2 has no effect on the trafficking of GluR2 (GluR2 MPR(AA) [wt]-control, 1.0 6 0.09; infected, 1.35 6 0.08; each, n = 10; GluR2 MPR-SS-control, 1.0 60.15; infected, 1.46 6 0.22; each, n = 16). (C) Introducing the GluR4 MPR-AEA motif in GluR1, however, has no effect on GluR1 trafficking (GluR1 MPR-SS [wt]-control, 1.0 6 0.06; infected, 1.06 6 0.06; each, n = 15; GluR1 MPR(AA)-control, 1.0 6 0.03; infected, 1.03 6 0.07; each, n = 12). *p < 0.05. Figure 3A as representative data). Furthermore, we tested if inhibition of endogenous PKC activity in the brain lysate could attenuate the phosphorylation of S818. Addition of the PKC inhibitory peptide (PKI) to the in vitro kinase assays with brain lysate resulted in a dose-dependent inhibition, indicating that endogenous PKC activity was responsible for GluR1 S818 phosphorylation. Moreover, the addition of PKC activators (phosphatidylserine and diacylglycerol) increased the phosphorylation of S818 by brain lysate ( Figure 3B ). These results suggest that S818 in GluR1 is a direct target for PKC phosphorylation in vitro.
Phosphorylation-Site-Specific Antibody Detects GluR1 S818 Phosphorylation In Vivo To study phosphorylation of GluR1 on S818 in vivo, we generated a phosphorylation-site-specific antibody (GluR1-pS818) against this site using a phosphopeptide KSRSEpSKRMKGF. The specificity of the GluR1-pS818 antibody was initially examined using the wild-type GST-GluR1C80 fusion protein phosphorylated with PKCa in vitro. As shown in Figure 4A , the antibody only detected the GST fusion protein after PKCa phosphorylation, confirming that this site is phosphorylated. In contrast, the antibody did not recognize fusion protein phosphorylated in vitro with CaMKII. In control experiments, a phosphospecific antibody for S831 (GluR1-pS831) detected GluR1 phosphorylated in vitro with PKCa or CaMKII ( Figure 4A ), consistent with previous studies (Barria et al., 1997; Mammen et al., 1997b) . To examine whether phosphorylation of GluR1 on S818 could occur in cells in culture, we transfected GluR1 into HEK293T cells and then immunoprecipitated GluR1 and analyzed the immunoprecipitates for phosphorylation using the GluR1-pS818 antibody ( Figure 4B ). As shown in Figure 4B , the basal phosphorylation of GluR1 on this site was low but could be increased by treatment of the cells with the PKC activator PMA. Moreover, robust phosphorylation of this site was observed in cells cotransfected with a constitutively active form of PKC ( Figure 4B ). These results show that GluR1 can be phosphorylated on S818 in vivo and that our GluR1-pS818 antibody can detect changes in phosphorylation at this site.
Finally, to determine whether this site is phosphorylated in brain in vivo, we performed immunoblot analysis of rat brain lysate (P2). In brain, the GluR1-pS818 antibody recognized two proteins, a major protein of approximately 105 kDa that corresponds to the size of the GluR1 subunit and an additional minor 150 KDa protein ( Figure 4C ). The 105 kDa phosphoprotein protein could be immunoprecipitated using a GluR1Nt antibody confirming that it was GluR1. Peptide block of the GluR1Nt antibody prior to immunoprecipitation completely eliminated the phosphoprotein signal, demonstrating the specificity of the pS818 antibody for the GluR1 subunit ( Figure 4C ). In addition, the phosphoprotein signal was not detected anymore by the GluR1-pS818 antibody after dephosphorylation treatment of the blot using l-phosphatase. These data demonstrate that S818 is phosphorylated in brain.
Mimicking Phosphorylation at S818 Promotes GluR1 Synaptic Incorporation
Having established that GluR1 S818 is phosphorylated by PKC, a kinase known to play a crucial role in plasticity, we wanted to determine the impact, if any, of this new phosphorylation site on GluR1 trafficking. In organotypic slices, GluR1 requires an LTP stimulus for synaptic incorporation . Mimicking phosphorylation at S818 by introducing an aspartate (S/D) had no effect on its synaptic incorporation (rectification was unchanged; Figure 5A ). However, as mentioned above, the cytoplasmic terminus of GluR1 contains two additional activity-dependent phosphorylation sites: S831 and S845 (Barria et al., 1997; Mammen et al., 1997b; Roche et al., 1996) . We reasoned that phosphorylation of S818 might work in concert with phosphorylated S831 and S845 to effect synaptic delivery of GluR1. To test this, phosphorylation of all three serines (i.e., S818, S831, and S845) was mimicked by mutating them to aspartates. These phosphomimetic mutations lead to a significant increase in rectification ( Figure 5A ), indicating that this form of the receptor is incorporated into the synapse. In contrast, mutating S831 and S845 to aspartates in the absence of mutating S818 did not result in GluR1 synaptic delivery. Therefore, mimicking phosphorylation at S818 together with S831 and S845 gains GluR1 access to the synapse.
We hypothesized that phosphorylation at S818 may neutralize the strong positive charges in the neighboring sequence (see Figure 1B) , ultimately leading to synaptic incorporation of GluR1. Although aspartate mutants are routinely used as phosphomimetics, we reasoned that the single negative charge of the aspartate residue may be less effective than the more highly charged phosphate molecule in neutralizing the positively charged amino acids. We therefore mutated in addition the lysine residue adjacent to the phosphomimetic aspartate in the MPR to alanine (S818D,K819A). Interestingly, this resulted in a stronger and more robust rectification ( Figure 5B ).
Given that GluR1(818D,819A) shows a stronger rectification value than GluR1(818D,831D,845D), we wanted to readdress the question whether mimicking phosphorylation in the MPR alone would be sufficient to drive the receptor into the synapse. Toward this end, we expressed a double aspartate MPR mutant (SES to DED), which resulted in a comparable significant rectification value like the GluR1(818D,819A) ( Figure 5B ), indicating synaptic incorporation. Thus, while S816 is normally not phosphorylated (see above), 816D,818D provides a stronger negative charge than 818D and more likely mimics a phosphate group at S818. The additional mutation of S831 and S845 to aspartates had no further enhancing effect on rectification. For convenience, we introduce the following notation for various phosphorylation sites: GluR1(DDDD) corresponds to S/D conversions at serines 816, 818, 831, and 845.
Interestingly, truncating the cytoplasmic terminus after the MPR, GluR1(DD-STOP) prevented incorporated into synapses, indicating that other domains of the cytoplasmic tail are important for regulated delivery of GluR1. Furthermore, mutating T887 to alanine (AGL), which disrupts interaction with PDZ proteins and blocks LTP , also prevents GluR1(DDDD) from reaching synapses ( Figure 5B ). Our results suggest that phosphorylation of S818 promotes the receptor delivery into the synapse and that additional phosphorylation at serines 831 and 845 may act synergistically to enhance the synaptic trafficking of GluR1. In addition, synaptic delivery of GluR1(DDDD) requires T887 and potential PDZ domain interactions, similar to the wild-type receptor (see, however, Kim et al. [2005] ).
When hippocampal slices are cultured in organotypic conditions, they maintain spontaneous neural activity that can participate in plasticity (e.g., Kolleker et al., 2003) . We tested if spontaneous activity was required for synaptic incorporation of GluR1(DDDD). When slices expressing GluR1(DDDD) were maintained in high Mg 2+ (conditions that suppress spontaneous activity), the receptor failed to incorporate into synapses ( Figure 5B ). This indicates that signaling processes, in addition to phosphorylation of GluR1 at S818, S831, and S845, are necessary for synaptic incorporation of GluR1.
The experiments above indicate that GluR1(DDDD) is incorporated into synapses. We tested next if such incorporation produced an increase in transmission. (A) GST-GluR1C80 protein (R1C) samples were phosphorylated in vitro with PKCa (+PKC) or CaMKII (+CaMKII) and were analyzed by 10% SDS-PAGE followed by Western analysis with anti-pS818 or anti-pS831 antibody. (B) HEK293T cells transfected with GluR1 cDNA with and without PKC cDNAs and treated with a PKC activator (PMA) as indicated. The GluR1 was then immunoprecipitated with GluR1Nt antibody and immunoblotted with anti-pS818 antibody. The phosphorylation on the S818 of GluR1 was significantly increased by coexpression of PKC and stimulation by PMA. (C) The phosphorylation-site-specific antibody raised against the pS818 of GluR1 detected in vivo phosphorylation on the GluR1 subunit from rat brain cortex. Solubilized brain lysate (P2) and protein sample immunoprecipitated with anti-GluR1Nt antibody with or without peptide block (Pep), were analyzed by 7.5% SDS-PAGE followed by immunoblotting with anti-pS818 antibody. The protein bands corresponding to GluR1 are indicated by arrows. The antibodies used for immunoblotting (IB) are indicated at the bottom of each panel. Molecular masses of standards are indicated in kDa on the left (A-C).
Surprisingly, cells expressing GluR1(DDDD) showed no difference in the amplitude of transmission relative to nearby noninfected neurons ( Figure 5C ). This suggests that GluR1(DDDD) is able to gain access to synapses and replace existing receptors rather than increasing their total number.
We wished to obtain additional support that phosphorylation at GluR1 S818 by endogenous PKC was sufficient to drive the receptor into synapses. Therefore, organotypic slices were infected with a virus expressing GluR1(SSDD). Two days later, we applied the PKC activator PMA for 15 min. Recordings from infected neurons displayed increased rectification, compared to noninfected neighboring neurons, indicating the recombinant receptor was incorporated into synapses ( Figure 5D ).
To test the role of S818, we expressed GluR1(SADD). Application of PMA did not drive this receptor into synapses. However, PMA stimulation did drive recombinant receptor into synapses in cells expressing GluR1(ASDD). These results support the biochemical data presented above, indicating that S818 is the only critical target residue permitting endogenous PKC to drive the receptor into synapses.
S818 Phosphorylation Increases during
Hippocampal LTP GluR1 is driven into synapses after LTP-inducing stimuli, and several studies (see below) indicate that PKC may be critical for LTP. To test if GluR1 is phosphorylated at S818 during LTP, we performed immunoblot analysis by introducing an aspartate has no effect on the synaptic incorporation of GluR1. Introducing the same mutation in the background of GluR1(831D,845D) leads to synaptic incorporation, not seen with 831D 845D alone (GluR1-control, 1.0 6 0.06; infected, 1.06 6 0.06; each, n = 15; GluR1(818D)-control, 1.0 6 0.07; infected, 1.03 6 0.06; each, n = 12; GluR1(818D,831D,845D)-control, 1.0 6 0.05; infected, 1.2 6 0.07; each, n = 16; GluR1(831D,845D)-control, 1.0 6 0.09; infected, 1.08 6 0.08; each, n = 23). (B) Neutralizing the positive charge of K819 adjacent to D818 leads to a stronger phenotype, indicating that the effect of the phosphorylation might act through this mechanism of charge neutralization. Therefore, mutating S816 and S818 to aspartate has a more robust effect on the delivery of GluR1. A C-terminal truncated version (-STOP) as well as a destroyed PDZ-domain (-AGL) impairs synaptic incorporation. So does 10 mM Mg 2+ by blocking spontaneous activity in the hippocampal slice (GluR1(818D,819A)-control, 1.0 60.07; infected, 1.34 6 0.16; each, n = 12; GluR1(816D,818D,831D,845D)-control, 1.0 6 0.05; infected, 1.38 6 0.09; each, n = 16; GluR1(816D,818D)-control, 1.0 6 0.06; infected, 1.3 6 0.07; each, n = 21; GluR1(816D,818D,STOP)-control, 1.0 6 0.05; infected, 1.04 6 0.05; each, n = 15; GluR1(816D,818D,831D,845D,AGL)-control, 1.0 6 0.06, n = 12; infected, 1.0 6 0.07, n = 15; GluR1(816D,818D,831D,845D+Mg 2+ )-control, 1.0 6 0.07; infected, 0.93 6 0.06; each, n = 15). (C) Normalized amplitudes of GluR1(816D,818D,831D,845D) indicates no net addition of GluR1 to the synapse (control, 1.0 6 0.06; infected, 1.08 6 0.17; each, n = 11). (D) Normalized rectification of PMA treated slice culture neurons infected with GluR1(831D 845D), GluR1(818A 831D 845D), and GluR1(816A 831D 845D). The mutation of S818 to alanine blocks the PKC-dependent delivery of GluR1, whereas mutating S816 has no effect (GluR1(831D,845D)-control, 1.0 6 0.09; infected, 1.08 6 0.08; each, n = 23; +PMA-control, 1.0 6 0.11, n = 13; infected, 1.38 6 0.13, n = 15; GluR1(818A,831D,845D)-control, 1.0 6 0.08; infected, 1.05 6 0.08; each, n = 10; +PMA-control 1.0 6 0.07, n = 14; infected, 1.06 6 0.08, n = 15; GluR1(816A,831D,845D)-control, 1.0 6 0.06; infected, 0.96 6 0.04; each, n = 12; +PMA-control, 1.0 6 0.08; infected, 1.3 6 0.09; each, n = 12). *p < 0.05. of organotypic slices after induction of a chemically induced form of LTP (chemLTP) (Otmakhov et al., 2004) . ChemLTP uses a combination of PKA activators and low Mg 2+ to increase spontaneous neuronal activation and activate NMDA receptors (Otmakhov et al., 2004) . This form of LTP results in enhanced transmission and drives GluR1 into synapses, both effects can be blocked by the PKC-inhibitor Chelerythrine (see Figure S1 in the Supplemental Data available with this article online; see also Kopec et al. [2006] ). As shown in Figures 6A and 6C chemLTP significantly increased the phosphorylation on S818 compared to control slices. As an internal control, we analyzed the phosphorylation state of S831, which has previously been shown to be regulated during LTP. The chemLTP significantly increased the phosphorylation on S831 ( Figures 6A and 6C) , consistent with previous studies using electrical stimulation for LTP induction in hippocampal slices (Barria et al., 1997; Lee et al., 2000) . In addition, induction of chemLTP produced a large increase in the phosphorylation of GluR1 on the PKA site, S845 ( Figures 6A and 6C ), resulting from the global activation of PKA by Forskolin in the chemLTP solution. These data indicate that GluR1 S818 undergoes phosphorylation during a chemically induced form of LTP. Furthermore, we also tested if the phosphorylation on S818 could be increased by LTP induced by electrical stimulation using protocol we developed in the previous study of GluR1 phosphorylation (Lee et al., 2000) . Similar to chemLTP, theta burst stimulation (TBS) significantly increased the phosphorylation on S818 as well as S831 ( Figures 6B and 6C ).
S818 Phosphorylation Is Required for LTP
Having shown that S818 in GluR1 is phosphorylated in a chemically induced form of LTP, we wanted to investigate if LTP requires S818 phosphorylation. First, we hypothesized that PKC phosphorylation of its MPR permitted GluR1 to interact with ''delivery'' proteins or to break a ''retention'' protein interaction, either of which could allow the receptor into the synapse. Thus, we tested the effects of a construct containing only the MPR with the corresponding serines 816 and 818 mutated to aspartates (MPR(DD)) or alanines (MPR(AA)). We predicted that if GluR1 phosphorylated at its MPR permits GluR1 to interact with a delivery protein, the MPR(DD) construct should compete with GluR1 for this delivery protein and block LTP. MPR(DD), however, should have no effect on basal transmission, as GluR1 is not constitutively delivered to synapses in this preparation (Shi et al., 2001) . If phosphorylation of GluR1 at its MPR breaks a retention interaction, the MPR(DD) should not block LTP, while MPR(AA) should compete for the interaction with the retention protein and facilitate LTP. The expression of MPR(DD) and MPR(AA) produced (A) ChemLTP (cLTP) was induced in organotypic slice cultures from rat hippocampus and analyzed by Western blot. The phosphospecific signal of GluR1 normalized to total GluR1 (GluR1-Ct) showed significant increase of phosphorylation for both S818 and S831 (114.5 6 4.5% and 114.6 6 3.8% of controls, n = 16; paired t test, p < 0.05). (B) LTP was induced using electrical stimulation in acute slices from rat hippocampus and analyzed by Western blot. Theta burst stimulation (TBS) significantly increased the phosphorylation on S818 and S831 (114.4 6 4.8% and 115.1 6 3.0% of controls, n = 8; paired t test, p < 0.05). The protein bands corresponding to GluR1 or a-tubulin are indicated by arrows. The antibodies used for immunoblotting (IB) are indicated at the bottom of each panel. Molecular masses of standards are indicated in kDa on the left (A and B). (C) Summary of phosphorylation changes after LTP induction. no effects on basal transmission ( Figure 7A ), supporting the absence of nonspecific interactions. We then tested for LTP in cells expressing MPR(DD). Transmission was monitored in two independent pathways, one of which was subjected to a pairing protocol to induce LTP. Following a brief potentiation, transmission returned to baseline by w30 min. The control pathway remained stable, indicating that the return to baseline was not due to a general rundown of transmission ( Figure 7B ). Overexpression of MPR(AA), however, did not block LTP ( Figure 7B ). Therefore, our results suggest that phosphorylation of GluR1-MPR by PKC permits GluR1 to establish new protein interactions, necessary for LTP.
In previous studies, we established that activation of CaMKII was sufficient to drive GluR1 receptors into synapses and mimics LTP. Thus, we tested if phosphorylation of GluR1 S818 is a prerequisite for CaMKII to drive receptors into synapses and thereby potentiate transmission. We employed an IRES construct to coexpress GluR1 with a truncated, constitutively active form of CaMKII, tCaMKII. As previously shown , coexpression of tCaMKII and wild-type GluR1 led to potentiated transmission ( Figure 8A ) and increased rectification ( Figure 8B ), indicating synaptic incorporation of recombinant GluR1. In contrast, coexpression of tCaMKII and GluR1 S818A produced no increase in rectification nor potentiated transmission. We conclude that GluR1 S818A acts in a dominant-negative manner to block CaMKII-induced synaptic incorporation of GluR1 and synaptic potentiation. It will be interesting in the future to determine if CaMKII activity promotes PKC phosphorylation of GluR1 or if these are parallel pathways activated during LTP.
As a final test, we examined the effect of GluR1 S818A on pairing-induced LTP. We reasoned that this construct may compete with endogenous GluR1 and prevent LTP. After two day expression of GluR1 S818A, no change in rectification was detected ( Figure 9A ), indicating that the receptor was not incorporated into synapses under basal conditions. In addition, the expression of GluR1 S818A had no effect on the amplitude of basal transmission. Following a LTP pairing protocol, neurons expressing GluR1 S818A displayed transmission that was significantly depressed relative to potentiation in control cells ( Figure 9B ). Taken together, these data show that S818 phosphorylation exerts a strong modulatory effect on LTP.
Discussion
In this study, we identify a phosphorylation site on GluR1, serine 818. This site is phosphorylated by PKC in vitro, in vivo, and following LTP in hippocampal slices. Phenocopying phosphorylation at serine 818 by sitedirected mutagenesis or pharmacologically inducing phosphorylation enables synaptic incorporation of GluR1. Expression of dominant-negative constructs based on this phosphorylation site reduces or blocks LTP.
There is considerable evidence that PKC plays an important role in LTP (Bortolotto and Collingridge, 2000; Hu et al., 1987; Hussain and Carpenter, 2005; Hvalby et al., 1994; Klann et al., 1993; Malenka et al., 1986; Malinow et al., 1989; Sacktor et al., 1993; Silva et al., 1995; Wang and Kelly, 1995 phosphorylation of these proteins contributes to plasticity. The role of GluR1 and its regulated incorporation into synapses during LTP is well supported (Broutman and Baudry, 2001; Hayashi et al., 2000; Heynen et al., 2000; Liao et al., 2001; Lu et al., 2001; Maren et al., 1993; Shi et al., 2001; Zamanillo et al., 1999) . Phosphorylation of GluR1 at serine 831 during LTP has previously been shown (Barria et al., 1997; Mammen et al., 1997b) , and this may be responsible for the increased single-channel conductance of AMPA receptors observed during LTP (Luthi et al., 2004) . However, mutation of serine 831 to alanine does not interfere with GluR1 synaptic incorporation during LTP , and knockin mice with S831 and S845 modified to alanine display only partial deficit in LTP (Lee et al., 2000) . Therefore, the new PKC phosphorylation site on GluR1 we report here presents a direct link between PKC and AMPA receptor trafficking during LTP.
The phosphorylated serine 818 lies in the MPR of GluR1. It is notable that serine 818 is conserved in GluR1 among different species (Figure 1B) , supporting an important role in its function. Serine 818 is one of two residues different among the MPR of the four AMPA receptor subunits, suggesting a possible regulatory role of this site. Indeed, replacement of an alanine with serine at this site in GluR4 changes its trafficking behavior (Figure 2A) . Replacement of the alanine in GluR2 does not affect its trafficking behavior ( Figure 2B) , consistent with the view that AMPA receptors with long (e.g., GluR1 and GluR4) or short (e.g., GluR2) cytoplasmic tails are ruled by different molecular constraints (Shi et al., 2001) .
The regulated synaptic trafficking of receptors can involve retention away from the synapse, delivery to the synapse, stabilization at the synapse, and removal from the synapse. In theory, phosphorylation of GluR1 at serine 818 could affect any of these processes and thereby its access to the synapse. Our experiments showing that expression of the dominant-negative construct MPR(DD) blocks LTP while MPR(AA) does not block LTP suggest that phosphorylation of GluR1 S818 is likely to act by facilitating an interaction with a delivery and/or stabilizing protein. A number of proteins bind to the MPR of glutamate receptors and could contribute to this delivery/stabilization of GluR1 in the synapse. 4.1N, an actin binding protein, is involved in the synaptic incorporation and stabilization of glutamate receptors (Shen et al., 2000) . The clathrin-interacting protein AP2 also binds the MPR of GluR1 and GluR2 (Lee et al., 2002) . The interaction of GluR2 and AP2 leads to receptor endocytosis, a mechanism that underlies LTD. The effect of AP2 on GluR1 has not been investigated, but one can speculate that the effect would be the same as for GluR2. The lipid kinase PI3-kinase, which also binds this site, is involved in the postsynaptic insertion of AMPA receptors during LTP . Blockade of PI3-kinse activity blocks the expression, but not the induction or maintenance of LTP (Sanna et al., 2002) . It is possible that phosphorylation of GluR1 S818 in the MPR may modify the binding to these proteins and thereby regulate receptor trafficking. Our initial biochemical studies have failed to identify such regulated, phosphorylation-dependent binding; however, more sensitive assays may be required to dissect the role of phosphorylation on these protein-protein interactions.
The synaptic incorporation of AMPA receptors during plasticity is known to depend on many signaling events and protein-protein interactions (Sheng and Kim, 2002) . In particular, Stargazin and other members of the TARP protein family have been shown to influence critically the trafficking of AMPA receptors (Chen et al., 2000) . How do the identified phosphorylation events by PKC, CaMKII, and PKA on GluR1 (S818, S831, and S845) and TARPs (nine phosphorylation sites on Stargazin; Tomita et al., 2005) interact to produce synaptic potentiation? In natural conditions, activity patterns likely produce spatially and temporally constrained activation of these kinases and targets within a neuron. One may imagine that only under plasticity-inducing conditions will there be simultaneous phosphorylation of several target sites; this conjunctive phosphorylation may be required to drive and maintain AMPA receptors and associated proteins at synapses. Such synergism is suggested by our results in which GluR1(SDDD) enters synapses while GluR1(SDSS) or GluR1(SSDD) do not. (Figure 5A ). Along this line, mimicking the full phosphorylation pattern on GluR1 (i.e., GluR1(DDDD)) is sufficient for synapticreceptor delivery but fails to increase transmission (Figure 5C ), suggesting that activation of additional proteins are required. It is notable that in some experimental conditions activation of single kinases (e.g., CaMKII [see Figure 8 and Lledo et al., 1995; Pettit et al., 1994] or PKC [Ling et al., 2002; Malenka et al., 1986] , or PKA [Frey et al., 1993] ) can produce LTP-like potentiation. It may be that persistent and strong activation of one kinase may lower the threshold sufficiently so that spontaneous or intermittent activation of other kinase pathways will drive trafficking. In this vein, it is also likely that different experimental conditions may display different signaling requirements. For instance, a recent study found that in their conditions mimicking phosphorylation at serines 831 and 845 sufficed to drive GluR1 into synapses; S818 may have been constitutively phosphorylated in their conditions (Qin et al., 2005) . If several independent signaling events are required to produce synaptic changes, then two important properties will ensue. First, modification of synaptic efficacy is unlikely to occur by chance, since there would be little likelihood for the simultaneous occurrence of several independent events. Second, plasticity could be independently modulated through several different signaling pathways.
In conclusion, we identify a PKC phosphorylation site on GluR1. The phosphorylation state of this site controls stable incorporation of GluR1 into the synapse. LTPinducing stimuli phosphorylate this site, and its phosphorylation is important for the establishment of LTP. With LTP stimuli, several phosphorylation events are likely to occur, both at receptors and associated proteins, which serve as multiple regulation sites to drive receptors into synapses and enhance synaptic transmission.
Experimental Procedures cDNA Mutagenesis and Subcloning for the Generation of GST-GluR1 Mutant Constructs Serine-to-alanine mutations (S/A) on GluR1 were created through the splicing by overlap extension polymerase chain reaction (SOE PCR; Ho et al., 1989; Horton et al., 1990) . Mutant PCR products containing the entire C-terminal domain of GluR1 plus a XhoI site immediately after the stop codon were generated for subcloning into pGEX.6P-3. The PCR fragments were cut with MseI (nt 2670), converted to blunt ends by Klenow fragment, then cut with XhoI for subcloning into SmaI-XhoI cut vector. The final fusion constructs contain amino acids 808-889 of GluR1 (GST-GluR1C80). All constructs were confirmed by DNA sequencing.
GFP-tagged AMPA-R subunits were previously described (Shi et al., 1999 (Shi et al., , 2001 ). The different S to A/D point mutations were introduced using the QuickChange XL-site-directed mutagenesis kit (Stratagene). GFP-GluR1-STOP was cloned by introducing a stop codon after the MPR and truncating the rest of the carboxyterminal tail. GFP-MPR was cloned by fusing the MPR directly to the GFP with a short linker in between. For viral expression, all constructs were subcloned in pSinRep5 of the Sindbis virus expression system (Invitrogen).
In Vitro Kinase Assay Bacterial glutathione S-transferase (GST) fusion proteins containing the carboxyl terminal of GluR1 were purified as described previously (Roche et al., 1996) . The purified GST-GluR1C80 fusion proteins were bound to glutathione Sepharose 4B beads (Amersham Biosciences). In vitro kinase assays were set up in 50 ml reactions containing 1.0 mM GST-GluR1C80 fusion protein, 10 mM MgCl 2 , and 25 mM ATP spiked with 0.01 mCi of [g-32 P]ATP (3000 Ci/mmol), using buffer conditions and kinase unit concentrations recommended by the manufacturers. In some cases, 10 mg of rat brain lysate was used as a source of kinase instead of purified kinases. Reactions were incubated at 30 C for 30 min immediately after adding the ATP, with frequent gentle mixing of samples to keep beads suspended. Reactions were stopped by adding 0.8 ml of ice-cold Tris-buffer including 10 mM EDTA. The beads were collected by centrifuging samples down, discarding the supernatants, resuspending the beads in 40 ml of SDS-PAGE sample buffer, and boiling for 5 min. Fifteen microliters of each sample were run on 12% SDS-PAGE, after which the gels were stained and destained to confirm equal loading of protein samples, then detected by using the Typhoon 9410 phosphorimager (Amersham Biosciences). All reactions were performed in duplicate. casein kinases and calmodulindependent protein kinases were purchased from New England Biolabs. Protein kinase C isoforms, Akt1, p70 S6 kinase, and Gsk-3b were from Upstate. PKA and Rsk were purified from Rat brains.
The PKC inhibitor peptide (PKI) RFARKGALRQKNVHEVKN was used at concentrations ranging from 0.2 mM to 20 mM. Lipid activators were used at final concentrations of 0.1 mg/ml phosphotidylserine and 0.01 mg/ml diacylglycerol.
Preparation of Rat Brain Lysate 1.68 g of adult rat cortex was added to 6.8 ml of Buffer A (0.32 M Sucrose, 1 mM microcystine, protease inhibitor cocktail [Complete, Roche] , and 4 mM HEPES [pH 7.4]) and homogenized using glass/ teflon homogenizer. After adding 10 ml of Buffer A, the extract was centrifuged for 10 min at 1400 3 g at 4 C. The supernatant was collected, spun again at 13,800 3 g for 10 min at 4 C, and the supernatant (S2) and pellet (P2) were saved. The pellet was resuspended in 3 ml of Buffer B (1% Triton X-100, 1 mM microcystine, protease inhibitor cocktail, 137 mM NaCl, 2.68 mM KCl, 10.1 mM Na 2 HPO 4 , 1.76 mM KH 2 PO 4 [pH 7.4]), mixed gently for 30 min at 4 C, and spun down at 14,000 3 g for 15 min to collect the solubilized P2 supernatant. Extracts were either used immediately or stored at 280 C.
Heterologous Expression of GluR1 and Kinase in HEK293T Cells
Human embryonic kidney (HEK) 293T cells were maintained in Minimal Essential Medium (MEM, Mediatech) containing 10% fetal calf serum (FCS), 2 mM L-Glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin at 37 C in 5% CO 2 incubator. The GluR1, PKC, and/ or CaMKII cDNAs were transiently transfected into the HEK 293T cells using the Lipofectamine 2000 (Invitrogen) as suggested by the manufacturer. After 48 hr incubation, the HEK cells were then treated with either control solution or a PKC activator (0.5 mM phorbol 12-myristate 13-acetate [PMA], Calbiochem) for 15 min, and the cell lysates were processed as described below.
cDNA clones used for heterologous expression of GluR1 and CaMKII were described previously (Mammen et al., 1997a) . pECE-PKC-a cDNA was a kind gift from Dr. Yanhua Hu.
Immunoprecipitation
Antibodies were bound to Protein A-Sepharose beads (Amersham Biosciences) by incubating at 4 C for 1 hr. Either brain or cell lysate solubilized in Buffer B were incubated with the antibody-Protein ASepharose beads at 4 C for 3 hr on a rolling platform. To show the specificity of immunoprecipitation, as a negative control, one group of samples was incubated with peptide that was used to raise that antibody (peptide block). After washing the beads three times with three-bed volume of ice-cold Buffer B, proteins bound to the antibodies were eluted with protein SDS-PAGE loading buffer (2% SDS, 1% b-mercaptoethanol, 0.005% Bromophenol blue, 2% glycerol, and 0.05 M Tris-HCl [pH 6.8]).
Antibodies and Immunoblot Analysis
The phosphorylation-site-specific antibodies against pS818 of GluR1 (GluR1-pS818) were raised against a synthetic peptide corresponding to amino acids 813-824 of GluR1, with phosphoserine included at the Ser-818 (KSRSEpSKRMKGF). The phosphorylationsite-specific antibodies were affinity purified from rabbit sera by sequential chromatography of the Affi-Gel 15 gel (Bio-Rad) columns covalently linked to unphosphorylated and Ser818-phosphorylated GluR1 peptides.
Antibodies specific for the pS831, pS845, and carboxyl tail of GluR1 subunit have been described previously (Mammen et al., 1997b) . Anti-GluR1 aminoterminal antibody (GluR1Nt antibody) was described previously (Mammen et al., 1997a) . The anti-a-Tubulin antibody was purchased from Sigma-Aldrich.
The brain lysate, cell lysate, brain-slice lysate, purified GSTGluRC80 fusion proteins, or immunoprecipitated proteins were resolved by SDS-PAGE under reducing conditions (1% b-mercaptoethanol) and transferred to polyvinylidene-difluoride (PVDF) membranes (Millipore). The PVDF blots were probed separately with affinity-purified antibodies at 4 C overnight. After staining with Horseradish peroxidase-conjugated secondary antibodies (Amersham Biosciences), the blots were developed by enhanced chemiluminescence (ECL) (SuperSignal or Western Lighting, PerkinElmer Life Sciences), and imaged using an image capturing system (ChemiDoc XRS, Bio-Rad). The captured digital images were quantified using Quantity One software (Bio-Rad) and statistically analyzed using Sigma-Plot software (SPSS Inc.) and presented by average 6 standard error of mean. Data in figures are representative of at least three independent experiments.
Slice Culture and Viral Infection
Hippocampal slices were prepared from p6/7 rat pups as previously described and maintained in culture for 6-10 days and infected with Sindbis virus as described earlier Shi et al., 2001) . For slices maintained in high Mg2 + , 10 mM MgCl 2 was added to the culture medium just before infection with Sindbis, but omitted during recordings.
Electrophysiology
Simultaneous whole-cell recordings were obtained from pairs of nearby (<50 mm apart) control and infected pyramidal neurons under visual guidance using differential interference contrast and fluorescence microscopy. The recording chamber was perfused with ACSF containing 119 mM NaCl, 2.5 mM KCl, 26 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 11 mM glucose, 0.1 mM picrotoxin (Sigma), and 1-4 mM 2-chloroadenosine (Sigma), at pH 7.4, bubbled with a mix of 5% CO 2 and 95% O 2 . Four millimolar CaCl 2 and 4 mM MgCl 2 were added to the ACSF for hippocampal slice cultures. All recordings were performed at 28 C. Patch pipettes (3-5 MU) were filled with internal solution containing: 115 mM cesium methanesulfonate, 20 mM CsCl, 10 mM HEPES, 2.5 mM MgCl 2 , 4 mM Na 2 ATP, 0.4 mM Na 3 GTP, 10 mM sodium phosphocreatine, 0.6 mM EGTA, at pH 7.25 and 290 mosm. For rectification analysis, 0.1 mM spermine (Sigma) was included in the internal solution and 0.1 mM APV (Sigma) in the ACSF. Whole-cell recordings were carried out using two Axopatch-1D amplifiers (Axon Instruments), and data were acquired and analyzed using custom software written in Igor Pro (Wavemetrics). Electrodes were placed over Schaffer collateral fibers w250 mm lateral to the recording site in hippocampal slice cultures. Stimulus intensity was adjusted so responses could typically be evoked in both cells. EPSC-amplitudes were obtained from an average of 60-80 sweeps at each holding potential. All recordings, except LTP, were done by stimulating two independent synaptic inputs; results from each pathway were averaged and counted as n = 1. The AMPA-mediated EPSC was measured as peak inward current at 260 mV, the NMDA-mediated component was measured as the late component (80-85 ms after stimulus) of the outward current at +40 mV. Rectification was calculated as the ratio of the peak AMPA current (in 100 mM D,L-APV) at 260 and +40 mV, corrected by current at 0 mV. Some rectification data and all LTP data were obtained recording from single neuron recordings (rather than paired recordings).
For phorbol ester activation of PKC, slices were incubated in medium containing 2 mM PMA for 15 min. Slices were then transferred to normal medium for 45 min prior to recording. Recordings were conducted up to 2 hr after PMA treatment.
LTP was induced by pairing 3 Hz stimulation with depolarization of the postsynaptic neuron to 0 mV for 3 min; recordings were maintained for at least 40 min after pairing. The EPSC amplitude was normalized to the average baseline amplitude before pairing. All data are reported as mean 6 SEM. Statistical analysis for paired recordings used the paired t test, for unpaired recordings using the Mann-Whitney test. Significance was set to p < 0.05.
For field recordings, slices were prepared as described above and a glass patch electrode (resistance 0.5-1.5MU) filled with ACSF was inserted into the cell body layer of the CA1 region. Synaptic transmission was evoked placing the stimulating electrode w300 mm down the apical dendrite and displaced horizontally 200 mm. Test pulses were delivered every 30 s. During the 16 min chemLTP induction and 20 min after, no test pulses were delivered. Statistical analysis compared the 20 min baseline with the recordings from 100-120 min.
Induction of LTP
Experiments were performed at 30 C in physiological ACSF (119 mM NaCl, 26 mM NaHCO 3 , 1 mM NaH 2 PO 4 , 11 mM D-glucose, 2.5 mM KCl, 4 mM CaCl 2 , 4 mM MgCl 2 , and 1.25 mM NaHPO 4 ) gassed with 5% CO 2 and 95% O 2 . The chemLTP induction solution consisted of the above ACSF lacking MgCl 2 and containing 100 nm Rolipram, 100 mm Forskolin, and 100 mm Picrotoxin (all dissolved in DMSO as 10003 stock solution). During the 16 min of chemLTP induction, 10 ml of each solution were allowed to flow through before recycling to prevent mixing of the solutions. The induction of LTP by TBS and phosphorylation analysis was performed as described previously (Lee et al., 2000) . As a control for successful LTP induction, field recordings were performed.
Supplemental Data
Supplemental Data for this article can be found online at http://www. neuron.org/cgi/content/full/51/2/213/DC1/.
